|
AUTHORS:
Robert
H. Demling, M.D. Leslie
DeSanti R.N.,
Dennis P. Orgill, M.D. Ph.D.
BIOSYNTHETIC SKIN
SUBSTITUTES: PURPOSE, PROPERTIES & CLINICAL INDICATIONS
A) PURPOSE AND DESIGN
CRITERIA OF ENGINEERED SKIN SUBSTITUTES
The evolution of biologic and synthetic
dressings began with the recognition that burn wounds require a barrier
protection to prevent infection and desiccation and cell guidance by dermal
elements to maximize healing. Properties of both layers of skin are important to
incorporate.
|
IMPORTANT
DEVELOPMENT CRITERIA
- bilayer
concept of wound coverage
- both
epidermal and dermal analogs necessary for successful skin
replacement
- outer layer
has a barrier function to facilitate healing
- dermal
elements important for cell guidance during re-epithelialization
- dermal
element will vary from an interface for healing (temporary
substitute) to incorporation of dermal elements (permanent
substitutes)
- restore
normal tissue architecture
- avoid scar
contracture
|
Increased understanding of the
optimization of healing partial thickness wounds, occurred with the noted
benefits of an adherent protective dressing, initiated the search for a
temporary skin substitute which had barrier properties plus adherence
properties. The addition of dermal components in particular collagen, have been
added after recognition of the wound healing properties of this protein.
The increasing survival of massive
burns, where available skin for auto grafting is very limited, has been the
initial stimulus for the development of a permanent skin substitute. The
increasing emphasis on rehabilitation and "quality of skin cover" has
further accelerated this field. A skin substitute which has properties of a
dermis is the marker for gauging a permanent substitute.
|
SKIN
SUBSTITUTES
- temporary
- material
designed to be placed on a fresh wound (partial thickness) and left
until healed
- semi-permanent-material
remaining attached to the excised wound, and eventually replaced by
autogeneous skin grafts
- permanent
incorporation
of an epidermal analog, dermal analog, or both as a permanent
replacement
|
|
REQUIREMENTS
FOR SUCCESS (BIOSYNTHETIC
SKIN SUBSTITUTE)
- solve a clinical problem
- approval by governmental
regulatory agency
- financially viable
|
|
AVAILABLE
BIOLOGIC AND SYNTHETIC SKIN
SUBSTITUTES
- Naturally
occurring tissues
- Cutaneous allografts
- Cutaneous xenografts
- Amniotic membranes
- Skin
substitutes
- Synthetic bilaminate
- Collagen based composites
Biobrane
TransCyte
Integra
- Collagen
based dermal analogs
- Deepithelized allograft
- Alloderm
- Culture-derived
tissue
- Bilayer human tissue (Apligraf)
- Cultured autologous keratinocytes
- Fibroblast seeded dermal analogs
- Collagen-glycosaminoglycan matrix
- Polyglycolic or acid mesh
- Epithelial seeded dermal analog
|
BIOLOGICALS (ALREADY
MADE) Available biologic materials include allografts and xenografts.
Allograft (cadaver
skin) has been considered the gold standard for temporary skin but eventual lack
of an epidermis eliminates its barrier function and the outer layer will need to
be added. Plus there is a major problem of availability. Its use in partial
thickness wounds is not practical.
Xenografts (tissue
from another species) is more accessible than allograft. However, xenografts
cannot re-vascularizes from the wound so the tissue breaks down and sloughs off
the wound.
B)
RATIONALE FOR DEVELOPING BIOSYNTHETICS
Given the limitations of available
biologic bilayer skin, the development of engineered skin substitutes became
necessary using synthetics and incorporating biological active components. The
biologically active agents have mainly been collagen and glycosamino glycan
components of dermal matrix. More recently viable cells namely human keratinocytes
and fibroblasts have become available through advances in bio-engineering
and culture techniques. Therefore, current bilayer skin substitutes are usually
composed of
- a synthetic component
- a biologically active component
C) SYNTHETIC
MATERIALS
Advances in the technology of polymer
chemistry has led to the develop of the epidermal analogs which are critical for
the function of both temporary and permanent skin substitutes.
|
IDEAL
PROPERTIES OF BIOSYNTHETIC SKIN SUBSTITUTE
- rapid and
sustained adherence to wound surface*
- impermeable
to exogenous bacteria
- water
vapor transmission similar to normal skin
- inner
surface structure that permits cell migration, proliferation and in
growth of new tissue
- flexibility
and pliability to permit conformation to irregular wound surface,
elasticity to permit motion of underlying body tissue
- resistance
to linear and shear stresses
- prevention
of proliferation of wound surface flora
- tensile
strength to resist fragmentation when removed
- biodegradability
(important for "permanently" implanted membranes
- low cost
- indefinite
shelf life
- minimal
storage requirements
- absence of
antigenicity
- tissue
compatibility
- absence of
local and systemic toxicity
*
The most important criteria is Adherence
|
|
AVAILABLE
SYNTHETIC MATERIALS FOR SKIN SUBSTITUTES
SOLID SILICONE POLYMERS
- uniquely permeable to
water vapor
- impermeable to bacteria
and toxins
- control evaporative water
loss
- flexible, durable,
non-antigenic
POLYURETHANE, POLYVINYL
- impermeable to bacteria,
toxins
- minimally permeable to
water vapor which can lead to fluid collections
- some flexibility
- difficult to add pores
without weakening structure
NYLON
- can make into a fine weave
markedly increasing surface area for contact
- can control adherence by
type of weave
- can bond collagen
- durable, non-allergenic
|
D) THE IMPORTANCE OF
COLLAGEN
The phenomenon of contact guidance of
cells to restore normal tissue anatomy is well recognized. Some cell alignment
properties can be provided with a micro filamentous synthetic material such as
nylon.
However numerous studies have
demonstrated the importance of a collagen contact interface with the
wound to guide the "healing process". Type one collagen provides
contact guidance for epithelial cells and fibroblast allowing optimal migration
and cell orientation.
Initial collagen based products lacked
an outer synthetic protective layer and were prone to environmental insults. The
rate of biodegradability which is related to the degree of cross-linking, is
controlled by increasing cross-linking. However, the denser the cross-linking,
the less the surface adherence and the stiffer the product. In addition,
porosity is decreased leading to fluid accumulation and less adherence.
PROGRESSION OF COLLAGEN
BASED DRESSINGS

|
Various views
of laminated collagen sponge dressing in scanning electron microscopy.
Left-top view showing multifilamentous gauze made of polyesther (A)
attached to self-adhesive film (B).
This lamination is permeable to air and secretions and has high
tensile strength. Middle-bottom layer of collagen sponge matrix
(700x). Right-side view, showing at the top cross-section through the
gauze filaments (A) and a
continuous film of a self-adhesive lamination (700x).
|
An advance was the addition of
glycosaminoglycan to provide more porosity and a more durable structure. A
further advance was the development of a bilaminar structure with an outer
synthetic layer acting as a barrier and controlling water vapor while the inner
layer acting as a dermal analog.
|
Characteristics
of Collagen Utilized in Skin Substitutes
|
| Physical |
Physical-Chemical |
Biological |
| high
tensile strength
low extensibility
complex surface
morphology
|
controllable
cross linking
regulating
solubility
swelling
tissue resorption
antigenicity
|
minimal
antigenicity by cross linking
chemotactic
stimulation of cell migration
adhesion site for cells
through fibronectin
|
| |
|
|
With the separation of skin substitute
into temporary and permanent the structure of the dermal collagen analog has
changed.
- Temporary skin substitute
- dermal analog not incorporated
- a collagen protein or collagen peptide provides epithelial cell
direction
- Permanent skin substitute
- dermal analog is incorporated to varying degrees to restore a
dermis
|
E) TEMPORARY SKIN
SUBSTITUTES FOR THE PARTIAL THICKNESS BURN
The objective of this approach is to
actively alter the quality and rate of healing of a partial
thickness burn. The approach is quite different from the standard treatment,
where the rate of healing is patient dependent and treatment is focused mainly
on infection control.
|
TEMPORARY
SKIN SUBSTITUTES
- control the wound healing
environment
- protection from healing
retardants (epidermal analog)
- biological enhancement of
the healing process (dermal analog)
|
|
TEMPORARY
SKIN SUBSTITUTES VERSUS TOPICAL ANTIBIOTICS
- Clinical Advantages Skin
Substitutes
- Markedly reduces pain
- Decreased heat, water loss
- Decreases wound inflammation, drainage
- Prevents surface drying in superficial wounds
- Increases rate of epithelialization
- Decreases surface infection
- Disadvantages
- Does not control deep infection
- Can seal bacteria in as well as out
- Biologicals can transmit infection
- Indications
- Superficial to mid second degree burn
- Clean, excised wound
- Skin donor sites
|
There are a number of products
advertised as temporary skin substitutes, only two are truly a skin substitute
having a bilayer with and epidermal and dermal components. These two products
are discussed briefly in this section and in detail in later sections.
|
CRITERIA
FOR USE
- since
adherence is essential for effectiveness, wound bed must be
debrided to viable tissue
- since
temporary skin substitutes have no intrinsic bacteriocidal
properties, the wound surface must not be infected
|
GOOD CANDIDATES FOR
TEMPORARY BIOSYNTHETIC SKIN SUBSTITUTES

Superficial 2° burn
after debridement

Scald burn in child

Clean superficial
mid-dermal burn

Superficial hand burn

Clean excised wound

Wide meshed skin
graft
2) NOT
GOOD CANDIDATES FOR TEMPORARY SKIN SUBSTITUTES

Mid-deep dermal burn:
too deep to allow for the necessary adherence as non-viable tissue on the
surface

Alkali burns: appear
less deep than the actual degree of tissue damage. Wound conversion is occurring
for hours after exposure. Surface typically is non-viable.
BILAYER TEMPORARY
SKIN SUBSTITUTES
|
BIOBRANE
- bilaminar
skin substitute
- outer
epidermal analog constructed of a thin silicone film with barrier
functions comparable to skin
- small pores
present in silicone to allow for exudate removal, permeability to
topical antibiotics
- inner dermal
analog composed of a three dimensional irregular nylon filament
weave upon which is bonded type I collagen peptides
- surface
binding of inner membrane potentiated by collagen-fibrin bonds as
well as fibrin deposition between nylon weave
- subsequently
fibronectin, produced by migrated fibroblasts, enhances binding to
the fibrin entrapped in mesh
- new
epithelial cells growing along mesh measures adherence
- thin water
layer at surface maintained for epidermal cell migration
- removed
after re-epithelialization (or prior to skin graft on excised wound)
- silicone and
nylon weave provides flexibility
- long shelf
life: maintained at room temperature
*
Bertek Pharmaceuticals Inc.
|
|
TRANSCYTE
- bilayer
skin substitute
- outer
epidermal analog is a thin nonporous silicone film with barrier
functions
- inner dermal
analog is layered human fibroblast products mainly collagen type I,
fibronectin and glycosaminoglycan
- subsequent
cryo-preservation destroys fibroblasts but preserves activity of
fibroblast derived products.
- thin water
layer at surface maintained for epidermal cell migration
- removed
after re-epithelialization (or prior to skin graft or excised wound
- silicone
provides flexibility
- must be kept
frozen until use (Smith and Nephew Wound Management)
|
E) COMPARISON OF
TEMPORARY SKIN SUBSTITUTE PROPERTIES
COMPARISON
OF THE ADHERENCE, PROPERTIES OF COMMONLY USED TEMPORARY SKIN SUBSTITUTES
(BIOSYNTHETICS VS. BIOLOGICALS)
| |
|
|
| Biobrane |
Allograft |
Pigskin |

* Adherence measured
in g/cm2
(At
72 hrs: Biobrane adherence significantly greater than biologic grafts)
EVAPORATIVE WATER LOSS (EWL)
(EXCISED WOUND)
| |
|
|
|
| Open
Wound |
Biobrane |
Allograft |
Pigskin |

At
Day 1: Biobrane and pigskin reduced EWL by 90% , while at 5 days Biobrane and
Pigskin had EWL comparable to normal skin. Note:
marked EWL of open wound (Pigskin-not meshed)
Antibiotic
Permeability (Biobrane with Pores) Permeability to 1% Silver Sulfadiazine

Click the Image to
Enlarge
(A new Composite Skin
Prosthesis, Travis M, Bartlett R, Woodroof E., Burns 1979; 7:123)
Adherence,
Pain, Infection Control
|
Comparative
Ranking of Skin Substitutes
|
| |
Adherence |
Pain
Control |
Infection
Control |
Durability |
| Biobrane |
1 |
same |
same |
1 |
| Pigskin |
2 |
same |
same |
2 |
| Allograft |
1 |
same |
same |
2 |
| |
Biobrane demonstrated
improved adherence and durability compared to porine xenograft and allograft.
Pain and infection control were comparable. (Comparison of Biobrane Porine and
Human Allograft as Biologic Dressings for Burn Wounds, Frank D. Wachlor T., et
al., Surg Forum 1980; 31:552)
F) PERMANENT SKIN
REPLACEMENT (FULL THICKNESS SKIN LOSS)
As opposed to the bilayer concept of
the ideal temporary skin substitute, permanent skin replacement is much more
complex.
This area can be arbitrarily divided
into two approaches. The first approach is the use of a bilayer skin substitute
with the inner layer being incorporated as a dermis rather than removed like a
temporary product. The outer layer is either a synthetic to be replaced by
autograft (epidermis) or both together. The outer layer of these products is
usually not sufficiently developed to act as a barrier upon initial placement.
The second approach is the
provision of either an epidermal or dermal components or simply a co-culture of
cells containing elements of both. These products are technically not skin
substitutes upon initial placement as there is no bilayer structure. Both
approaches will be discussed.
|
Permanent
Skin Replacement
- bilayer structures with
biologic dermal analog and either synthetic or biologic epidermal
analog
- skin components
- epidermal cells alone
- dermis alone
- co-culture of epidermal cells and fibroblasts
|
BILAYER
PERMANENT SKIN SUBSTITUTES
|
INTEGRA
(BILAYER WITH
BIOACTIVE DERMAL ANALOG
|
- dermal analog of a
biodegradable collagen-glycosaminoglycan co-polymer matrix
- epidermal analog is a thin
silicone elastomer providing environmental barrier protection and
water flux similar to normal skin
- collagen type I and
glycosaminoglycan have biologic wound healing activity
- collagen and the GAG is
cross linked in such a manner as to maximize in growth of cells and
control the rate of matrix degradation
- after neodermis formation,
the epidermal analog (silicone) is removed and replaced with thin
epidermal autograft or cultured epithelial cells
- major causes of loss of
dermal analog are infection and shearing with devascularizatin
- stored in 70% isopropyl
alcohol
- development in progress
is seeding of dermal analog
with epidermal cells which could then produce epidermis (a one step
skin replacement process)
- clinical trials have been
performed in burns
(* Integra
Life Sciences)
|
| |
|
APLIGRAF
(BILAYER HUMAN
EPIDERMIS & DERMAL ANALOG)
|
- dermal
analog is collagen matrix populated with fibroblasts which produced
a dermal layer
- dermal
elements obtained from neonatal foreskin
- dermal layer
incorporates
- epidermis is
stratified and multilayer providing biologic barrier function
- epidermis
also obtained from neonatal foreskin
- composite
repopulated by host cells
- clinical
trials data in burns not yet available
(Apligraf
Living Skin Equivalent, Organogenesis Inc., Canton MA)
|
| |
|
COMPOSITE
CULTURED SKIN (NOT TRUE BILAYER ON APPLICATION)
|
- keratinocyte,
fibroblast co-culture in cross linked bovine collagen sponge
- non-porous
side of sponge is seeded with keratinocytes from neonatal foreskin
- porous side
of sponge seeded with fibroblasts from neonatal foreskin
- epidermal
analog or protective barrier requires 14 days to develop with full
adherence to dermis reported
- multicenter
trial on use in burns is underway
(Composite
cultured skin: Ortec International, NY, NY)
|
| |
EPIDERMIS ONLY
|
Cultured
Epithelial Autograft (CEA)
|
- epidermal
layer replacement only
- use of
cell culture technology to grow small sample of patients
keratinocytes up to 10,000 fold in surface area
- 2-3 week
period to produce desired amount
- application
on excised wounds or over incorporated allograft dermis
- multilayer
confluent epithelial sheet forms
- epidermal-wound
junction has incomplete basement membrane and low resistance to
sheer forces
- graft take
on excised wound (28-50%) and on incorporated allograft dermis is
45-75%
- clinical
data available on use in burns
(Epicel-CEA
Genzyme Tissue Repair, Cambridge, MA)
|
| |
DERMAL REPLACEMENTS
ONLY
|
Alloderm
- Allograft Dermis
|
- allograft
epithelium removed
- dermis
treated to produce a cryopreserved lyophilized allodermis
- not a
bilayer product but acts strictly as a dermal transplant
- no
protective epidermal analog
- product
incorporation
- requires
application of thin epithelial autograft
- potential
problem of limited supply of allograft
- no
comparative studies as yet with other permanent skin substitutes
(Alloderm
Life Cell Corp, Woodlands, Texas)
|
| |
|
COLLAGEN
MATRIX ALONE
- not
bilayer product
- collagen
matrix dermal analog fabricated with cross linked bovine collagen
and denatured collagen (gelatin)
- no
epidermal analog
- thin
autograft applied after incorporation
- not
available in the United States
(Terudermis
Terumo Co., Kanagawa, Japan)
|
EPIDERMAL CELLS AND
FIBROBLASTS PLACED AS A CO-CULTURE
|
CULTURED
EPITHELIAL AUTOGRAFT PLUS CULTURED FIBROBLAST
- confluent sheet of
keratinocytes plus fibroblasts
- (neonatal foreskins)
- no real barrier function
on application
- bilayer to be developed
after application
- no clinical studies in
burns yet available
(Lifeskin
Culture Technology, Sherman Oaks, CA)
|
SUMMARY
The scientific principles and practical
approaches to replace skin temporarily or permanently are advancing at a rapid
rate. Much of these advances can be attributed to both advances in the field of
bio-engineering as well as increasing interest in optimizing the outcome of the
burn wound.
The ideal properties of a temporary and
a permanent skin substitute have been well defined.
As expected, the arena of temporary
skin substitutes is more concrete, easier to categorize and determine efficacy
with a bilayer structure being the current standard. Permanent skin replacement
on the other hand is much more complex. A variety of approaches are being used
which can be loosely categorized as either use of bilayer products (usually the
outer layer to be replaced by epidermal autograft or replacement of either
dermal or epidermal elements. The terminology of the latter approach is
difficult because these component products are nearly not skin substitutes on
initial application but become so only when all the elements are in place.
For now, understanding the properties
of each product is essential for the user to optimize outcome.
|